Trial intelligence / Profile preview

Naltrexone in Trichotillomania

NCT00775229Phase 2Completed

Sponsor
University of Chicago
Start
Aug 2008
Primary completion
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of naltrexone in trichotillomania (TTM), sponsored by University of Chicago. Started Aug 2008; status: completed.

02

Drugs

naltrexone
03

Conditions

trichotillomania (TTM)

Beyond the preview

Go deeper on NCT00775229.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00775229.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call